Rayonier Advanced Materials Past Earnings Performance
Past criteria checks 0/6
Rayonier Advanced Materials has been growing earnings at an average annual rate of 3.2%, while the Chemicals industry saw earnings growing at 9.5% annually. Revenues have been growing at an average rate of 2.5% per year.
Key information
3.2%
Earnings growth rate
7.3%
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | 2.5% |
| Return on equity | -12.0% |
| Net Margin | -5.4% |
| Last Earnings Update | 28 Sep 2024 |
Recent past performance updates
Recent updates
Market Might Still Lack Some Conviction On Rayonier Advanced Materials Inc. (NYSE:RYAM) Even After 35% Share Price Boost
Aug 08
Here's Why Rayonier Advanced Materials (NYSE:RYAM) Is Weighed Down By Its Debt Load
Mar 22Rayonier Advanced Materials: Despite Selling Assets, Looks Quite Undervalued
Nov 13Rayonier Advanced Materials: Uncovering Value In The Niche Of High Purity Cellulose
Jul 25Is Rayonier Advanced Materials (NYSE:RYAM) A Risky Investment?
May 13Rayonier Advanced Q4 2022 Earnings Preview
Feb 26Rayonier Advanced Materials Offers Opportunity As Pricing Improves
Jan 10Rayonier Advanced Materials expects force majeure to reduce EBITDA
Dec 27Rayonier Advanced Materials: EBITDA And Refinancing Senior Notes
Dec 20Rayonier Advanced Non-GAAP EPS of $0.28 beats by $0.18, revenue of $466M beats by $39.25M
Nov 01Is Rayonier Advanced Materials (NYSE:RYAM) Using Debt Sensibly?
Aug 24Rayonier Is Far Too Cheap
Aug 13Rayonier Advanced Materials (NYSE:RYAM) Has Debt But No Earnings; Should You Worry?
Apr 08Does Rayonier Advanced Materials (NYSE:RYAM) Have A Healthy Balance Sheet?
Nov 10Revenue & Expenses Breakdown
How Rayonier Advanced Materials makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 28 Sep 24 | 1,630 | -88 | 82 | 0 |
| 29 Jun 24 | 1,598 | -82 | 79 | 0 |
| 30 Mar 24 | 1,564 | -105 | 77 | 0 |
| 31 Dec 23 | 1,643 | -102 | 78 | 0 |
| 30 Sep 23 | 1,721 | -37 | 80 | 0 |
| 01 Jul 23 | 1,819 | 8 | 80 | 0 |
| 01 Apr 23 | 1,832 | -1 | 89 | 0 |
| 31 Dec 22 | 1,717 | -27 | 87 | 0 |
| 24 Sep 22 | 1,591 | -59 | 96 | 0 |
| 25 Jun 22 | 1,499 | -91 | 94 | 0 |
| 26 Mar 22 | 1,441 | -58 | 84 | 0 |
| 31 Dec 21 | 1,408 | -50 | 80 | 0 |
| 25 Sep 21 | 1,405 | -51 | 69 | 0 |
| 26 Jun 21 | 1,355 | -24 | 69 | 0 |
| 27 Mar 21 | 1,338 | -36 | 71 | 0 |
| 31 Dec 20 | 1,344 | -38 | 75 | 0 |
| 26 Sep 20 | 1,440 | -66 | 82 | 0 |
| 27 Jun 20 | 1,533 | -95 | 88 | 0 |
| 28 Mar 20 | 1,659 | -114 | 87 | 0 |
| 31 Dec 19 | 1,431 | -93 | 81 | 0 |
| 28 Sep 19 | 1,789 | -67 | 94 | 0 |
| 29 Jun 19 | 1,874 | -24 | 100 | 0 |
| 30 Mar 19 | 1,876 | 33 | 102 | 0 |
| 31 Dec 18 | 1,957 | 86 | 97 | 0 |
| 29 Sep 18 | 1,825 | 373 | 110 | 0 |
| 30 Jun 18 | 1,533 | 359 | 95 | 0 |
| 31 Mar 18 | 1,282 | 326 | 93 | 0 |
| 31 Dec 17 | 940 | 310 | 83 | 0 |
| 23 Sep 17 | 843 | 28 | 55 | 0 |
| 24 Jun 17 | 840 | 35 | 51 | 0 |
| 25 Mar 17 | 852 | 53 | 41 | 0 |
| 31 Dec 16 | 869 | 68 | 43 | 0 |
| 24 Sep 16 | 879 | 73 | 40 | 0 |
| 25 Jun 16 | 930 | 85 | 42 | 0 |
| 26 Mar 16 | 938 | 66 | 43 | 0 |
| 31 Dec 15 | 941 | 55 | 48 | 0 |
| 26 Sep 15 | 948 | 19 | 47 | 0 |
| 27 Jun 15 | 944 | 6 | 45 | 0 |
| 28 Mar 15 | 936 | 11 | 44 | 0 |
| 31 Dec 14 | 958 | 32 | 40 | 0 |
| 27 Sep 14 | 991 | 106 | 36 | 0 |
| 28 Jun 14 | 963 | 126 | 34 | 0 |
| 31 Mar 14 | 1,005 | 171 | 34 | 0 |
| 31 Dec 13 | 1,047 | 220 | 36 | 0 |
Quality Earnings: RYAM is currently unprofitable.
Growing Profit Margin: RYAM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RYAM is unprofitable, but has reduced losses over the past 5 years at a rate of 3.2% per year.
Accelerating Growth: Unable to compare RYAM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RYAM is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (4.8%).
Return on Equity
High ROE: RYAM has a negative Return on Equity (-11.95%), as it is currently unprofitable.